News

November 22, 2024

Official Press Release for Barricade Therapeutics – CPRIT Award

November 20, 2024

Barricade Therapeutics secures $14M Cancer Prevention Institute of Texas (CPRIT) grant to advance colorectal cancer treatment.

February 20, 2020

North Texas Startup, renowned UTSW researcher attract $21M from Texas cancer fighting agency

February 19, 2020

Barricade Therapeutics received $3M product development seed award from Cancer Prevention Research Institute of Texas (CPRIT).

Events

Barricade Therapeutics is planning to attend and/or presenting at the following upcoming events:

ASCO – American Society of Clinical Oncology Annual Meeting

AACR - American Association for Cancer Research

Publications

TASIN in Colorectal Cancer:

Selective targeting of mutant adenomatous polyposis coli in colorectal cancer.

Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.

TASIN in Other Cancers: Neuroblastoma and Burkitt's Lymphoma

7-dehydrocholesterol dictates ferroptosis sensitivity.

7-dehydrocholesterol is an endogenous suppressor of ferroptosis.

TASIN in Neurology / Demyelinating Disease: Multiple Sclerosis (MS)

Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination.